CITIC Securities: The domestic mRNA new crown vaccine has been approved for clinical trials one after another, and it is recommended that the upstream supply chain localization potential benefit targets


Full Data

?
UNLOCK DATA

Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login